Thanks Kam, appreciate the extra commentary. Interesting that generics pricing still being called out. Did she mention anything re specialty performance? I'd expect generic price deflation to be an ongoing concern and the only way you get around that is by continually launching new products (which they seem to have some new approvals this year and then a handful of new products with the Novast deal). I suppose I'm hopeful specialty hasn't been it too hard due to COVID. We need one of these bloody major approvals to land soon. Maybe there hasn't been any updates as one of the target action dates is between now and reporting day next Friday? Possibly hoping some good news might soften the blow... or who knows, maybe the report will be better than expected, and hopefully not just because of FX fluctuations!
MYX Price at posting:
35.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)